Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2017 08:15 ET | Source: Minerva Neurosciences, Inc.

Minerva Provides Update on Phase 3 Design and Development Strategy for MIN-101

Advancing a new potential therapeutic paradigm for the treatment of negative symptoms, a key unmet need in schizophrenia and other brain diseasesCompany to host conference call on May 16, 2017 at...